Company: DHR
Filing Date: 2025-03-26
Form Type: DEF 14A
Source: 0000313616-25-000081
Chunk: 6

Company: DANAHER CORP /DE/
Filing Date: 2025-03-26
Form: DEF 14A
Chunk 6
---
 |     |                 |     | Committees:                   |
| •Global/International                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
 •Life Sciences                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
 •Diagnostics                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
 •Healthcare Management                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |     | •Product Innovation                  
 •Public Company CEO and/or President 
 •Government, Legal or Regulatory     |     |                 |     | •Science & Technology (Chair) 
 •Nominating & Governance      |

| ü |     | THE BOARD OF DIRECTORS RECOMMENDS A VOTEFOREACH OF THE FOREGOING NOMINEES. |

Board Composition, Refreshment and Selection

Our Approach to Board Composition and Refreshment

The composition of our Board is a key component of Danaher’s success. Our strategy and our diverse portfolio of leading science and technology businesses require a Board with the collective experience and perspective to lead us as we:

• expand in high-growth geographies and high-growth market segments;

• identify, consummate and integrate appropriate acquisitions;

• develop innovative and differentiated new products and services;

• respond to rapidly changing technologies, business cycles and competition; and

• address the demands of a dynamic regulatory environment.

At least annually, our Nominating & Governance Committee uses our Board skills matrix as well as the results of our annual Board, committee and individual director evaluation process to assess Board composition and make recommendations to complement and enhance our current Board, considering in particular relevant experience; tenure and diversity of skills, background and experience; capacity; and refreshment.

| 2025 Notice of Annual Meeting and Proxy Statement |     | 16 |

• Relevant experience . The evolution and refreshment of our Board over more than a decade reflects the evolution of our portfolio. As we have sharpened our strategic focus in the areas of healthcare and life sciences, we have added to our Board an expert in artificial intelligence and world-renowned physicians and scientists with expertise in medicine and medical care, molecular research, clinical trials, data science, healthcare policy and academia.

◦ Recognizing the breadth of our Board’s responsibilities, we’ve also further enhanced our existing capabilities in areas such as technology, capital allocation, corporate finance, accounting, risk management and compliance.

• Tenure and diversity of skills, background and experience . Our Board believes that the experience of our directors is enhanced by the balance of tenures, and the diverse skills, backgrounds and experiences, reflected on our Board.

◦ Given the critical role of acquisitions